Consensus Definition and Preliminary Validation Of a Low Disease Activity State In Systemic Lupus Erythematosus

被引：0
|
作者：
Morand, Eric F. [1 ]
Franklyn, Kate [1 ]
Lau, Chak S. [2 ]
Navarra, Sandra V. [3 ]
Louthrenoo, Worawit [4 ]
Lateef, Aisha [5 ]
Hamijoyo, Laniyati [6 ]
Wahono, Singgih [7 ]
Chen, Shun-Le [8 ]
Ou, Jinou [9 ]
Hoi, Alberta Y. [1 ]
Nikpour, Mandana [10 ]
机构：
[1] Monash Univ, Melbourne, Vic 3004, Australia
[2] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Univ Santo Tomas Hosp, Manila, Philippines
[4] Fac Med, Chiang Mai, Thailand
[5] Natl Univ Singapore, Singapore 117548, Singapore
[6] Hasan Sadikin Hosp, Bandung, Indonesia
[7] Univ Brawijaya, Malang, Indonesia
[8] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China
[9] Sun Yat San Univ, Hosp 3, Guangzhou, Guangdong, Peoples R China
[10] Univ Melbourne, Fitzroy, Vic 3065, Australia
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1566
引用
收藏
页码：S664 / S665
页数：2
相关论文
共 50 条
  • [1] CONSENSUS DEFINITION OF A LOW DISEASE ACTIVITY STATE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Lau, C. S.
    Nikpour, M.
    Navarra, S. V.
    Louthrenoo, W.
    Lateef, A.
    Hamijoyo, L.
    Wahono, C. S.
    Chen, S. L.
    Jin, O.
    Hoi, A.
    Morand, E. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 267 - 267
  • [2] CONSENSUS DEFINITION OF A LOW DISEASE ACTIVITY STATE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Morand, E.
    Lau, C.
    Navarra, S.
    Louthrenoo, W.
    Lateef, A.
    Hamijoyo, L.
    Wahono, C.
    Chen, S.
    Jin, O.
    Hoi, A.
    Nikpour, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 17 - 18
  • [3] PRELIMINARY VALIDATION OF A LOW DISEASE ACTIVITY STATE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Franklyn, K.
    Morand, E.
    Hoi, A.
    Nikpour, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 36 - 36
  • [4] Toward the Definition of Low Disease Activity in Systemic Lupus Erythematosus
    Polachek, Ari
    Gladman, Dafna
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1186 - 1187
  • [5] Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
    Golder, Vera
    Kandane-Rathnayake, Rangi
    Huq, Moth
    Nim, Hieu T.
    Louthrenoo, Worawit
    Luo, Shue Fen
    Wu, Yeong-jian Jan
    Lateef, Aisha
    Sockalingam, Sargunan
    Navarra, Sandra, V
    Zamora, Leonid
    Hamijoyo, Laniyati
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Chan, Madelynn
    O'Neill, Sean
    Goldblatt, Fiona
    Lau, Chak Sing
    Li, Zhan Guo
    Hoi, Alberta
    Nikpour, Mandan
    Morand, Eric F.
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (02): : E95 - E102
  • [6] Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS)
    Enas I. Abdelhady
    Mona Rabie
    Rofaida A. Hassan
    [J]. Clinical Rheumatology, 2021, 40 : 4553 - 4558
  • [7] Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS)
    Abdelhady, Enas, I
    Rabie, Mona
    Hassan, Rofaida A.
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4553 - 4558
  • [8] Prospective Multicenter Validation Study of the Lupus Low Disease Activity State - a Treatment Target for Systemic Lupus Erythematosus
    Golder, Vera
    Kandane-Rathnayake, Rangi
    Huq, Molla
    Louthrenoo, Worawit
    Luo, Shue-Fen
    Wu, Yeong-Jian
    Lateef, Aisha
    Sockalingam, Sargunan
    Morton, Susan
    Navarra, Sandra V.
    Zamora, Leonid
    Hamijoyo, Laniyati
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Chan, Madelynn
    O'Neill, Sean
    Goldblatt, Fiona
    Lau, Chak Sing
    Li, Zhan-Guo
    Hoi, Alberta Y.
    Nikpour, Mandana
    Morand, Eric
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [9] Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
    Franklyn, Kate
    Lau, Chak Sing
    Navarra, Sandra V.
    Louthrenoo, Worawit
    Lateef, Aisha
    Hamijoyo, Laniyati
    Wahono, C. Singgih
    Chen, Shun Le
    Jin, Ou
    Morton, Susan
    Hoi, Alberta
    Huq, Molla
    Nikpour, Mandana
    Morand, Eric F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1615 - 1621
  • [10] Utility of the Lupus Low Disease Activity State Definition in Discriminating Responders in the Phase IIb Muse Trial of Anifrolumab in Systemic Lupus Erythematosus
    Morand, E.
    Berglind, A.
    Sheytanova, T.
    Tummala, R.
    Illei, G.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345